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LocalizationAmyloid beta (Aβ) peptides, produced through endo-proteolytic cleavage of amyloid precursor protein, are
thought to be involved in the death of neural cells in Alzheimer's disease (AD). Although the mechanisms are
not fully known, it has been suggested that disruption of cellular activity due to Aβ interactions with the cell
membrane may be one of the underlying causes. Here in, we have investigated the interaction between Aβ-42
and biomimetic lipid membranes and the resulting perturbations in the lipid vesicles. We have shown that Aβ
oligomeric species localized closer to the membrane surface. Localization of the ﬁbrillar species of Aβ-42,
although varied, was not as closely associatedwith themembrane surface.We have demonstrated that the pres-
ence of Aβ-42 leads to an increase in membrane surface area, inducing lipid temporal vesicular transformation.
Furthermore, we have unequivocally shown that Aβ-peptides mediate membrane fusion. Although membrane
fusion induced by Aβ has been hypothesized/proposed, this is the ﬁrst time it has been visually captured. This
fusionmay be one of the mechanisms behind the membrane increase in surface area and the resulting vesicular
transformation. We have shown that the longer ‘amyloidogenic’ isoform causes vesicular transformation more
readily, and has a higher membrane fusogenic potential than Aβ-40. Although not core to this study, it is hugely
interesting to observe the high agreement between membrane dynamics and the reported amyloidogenicity of
the peptides and aggregation species opening up the potential role of vesicular dynamics for proﬁling and
biosensing of Aβ-induced neuro-toxicity.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Structural organizations such as lipid packing are intrinsic prop-
erties of cell membranes and contribute to biophysical processes
such as endo-, exo-cytosis, and membrane fusion. Membrane fusion
events play a role in fertilization, transmission of neurotransmitters
across synapses, intracellular trafﬁcking and recycling of membrane
components such as signaling molecules [1–3]. Membranes do not
spontaneously undergo fusion because there are high energy barriers
to overcome such as strong hydrophobic and steric repulsion forces
[4]. Fusogenic peptides and proteins mediate membrane fusion [5].
The conformational analysis of the C-terminal of amyloid beta (Aβ)
peptides (residues 29-40/42) is reported to have similar properties to
those of fusion peptides of viral proteins [6]. Several studies have
reported that Aβ induce destabilization of organelles in various cells
[7–11]. Aβ is strongly implicated in causing neurotoxicity associated
with Alzheimer's disease (AD) [12–14].
Alzheimer's disease is an age-related cognitive impairment, affecting
more than 18 million peopleworld-wide [15]. Although the involvement
of Aβpeptides into the neurotoxicity that eventually leads to AD iswidely
reported, the mechanism bywhich the peptide exert neurotoxicity is notl rights reserved.well understood and is a subject of intense research. Since research on
Aβ's role in AD is broad, we will focus our discussions around research
involving Aβ interactions with membrane, with the aim of elucidating
the mechanisms by which this peptide causes neurotoxicity. Studies on
the interactions between Aβ and lipids, the effect of lipid and cholesterol
compositions on oligomerization and ‘backward’ oligomerization have
been reported [16–18]. Most studies have concentrated on the effect of
biomolecules of Aβoligomerization and assembly [19,20]. In our research,
we focus on any changes to the biophysical processes of the membrane,
manifested for example, as membrane ﬂuctuation/pertubation, morpho-
logical transformation and/or membrane fusion. We utilize cell-sized
bi-layered model membranes.
Giant unilamellar vesicles (GUVs), that is, model membranes with
diameters greater than 10 μm have been used for investigations of the
physical and biological properties of vesicle membranes. The cell-sized
vesicles allow real-time observation of dynamicmorphological changes
to be clearly visualized,without compromising on the “controllable” an-
alytical advantage [21]. They also mimic the physiological environment
closely in terms of the spatio-temporal scale at which interactions take
place, thus allowing the understanding and clariﬁcation of mechanisms
[22–27]. It is therefore, expected that the GUV method will provide
a great deal of new information on the structure and function of
biomembranes and lipid membranes which cannot be obtained by the
studies on the LUVs and SUVs [21]. In this study, we used such vesicles.
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and morphological transformations. The membrane changes followed
two main pathways that culminated in sphero-stomatocyte formation.
A biophysical characterization of one of the pathways showed substan-
tial increase in membrane surface area, and a decrease in inner volume.
This particular pathway, was triggered by oligomeric species, and not
ﬁbrillar species. We hypothesized that the increase in surface area
could have either been due to the peptide inserting into the membrane
surface among the phospholipid bilayer, and/or the peptide recruiting
lipid molecules and small vesicles into the mother vesicle [26]. Here,
we have studied three different issues: (a) we have investigated the
effect of Aβ-42 on the biophysical properties of model membrane.
Aβ-40/42 are cleaved from a transmembrane protein called amyloid
precursor protein (APP). Research has shown that the bigger isoform
is more amyloidogenic than the shorter one [28]. We have compared
membrane dynamics induced by Aβ-42 with those caused by Aβ-40;
(b) In our previous study [26], we hypothesized that lipid recruitment
to the mother vesicle and/or membrane fusion were the mechanism
behind the observed increase in membrane surface area that lead to
membrane transformation. We have elucidated the mechanism by
which the mediation of membrane fusion processes by Aβ, and how
this relates to membrane dynamics. In addition, we have (c) established
localization of different Aβ aggregation species onto the membrane sur-
face, and the relationship between localization andmembrane dynamics.
Previously, we reported that interaction between Aβ aggregation species
andheterogeneousmembranes. Aβ tend to localize in the Ld-phase of the
Lo/Ld phase-separated membranes [29,30].
Our results show that Aβ-42 induces a higher membrane response
(structural re-organization), through a broader range of membrane
transformation pathways than Aβ-40. The longer isoform also has a
higher fusogenic potential than Aβ-40. Previously, Dante et al., using
small-angle neutron scattering, reported that the presence of Aβ-42
increased the radii of vesicles by about 80 Å. The authors then conclud-
ed that such an increase could only occur if there wasmembrane fusion
since peptide penetration and/or increase in area per molecule of lipid
could not induce such a large change [31]. In our work, we have
unequivocally visualized small vesicle recruitment and membrane
fusion upon introduction of Aβ. These processes lead to increase in
membrane surface area, inducing membrane transformation (sphero-
stomatocyte) as the vesicle hankers to re-attain a more favorable energy
state.
2. Material and methods
2.1. Materials
1,2-dioleoyl-sn-glycero-3-phosphocoline (DOPC) obtained from
Avanti Polar Lipids (Alabaster, AL). Fluorescent phospholipids, N-(rhoda-
mine red-X)-dihexadecanoyl-sn-glycero-phosphoethanolamine triethyl
ammonium salt (rho-PE, λex=560 nm, λem=580 nm) obtained
from Invitrogen. Aβ-peptides (Human, 1-40, 1-42) triﬂuoroacetate
salt (Aβ-40, -42) was purchased from Peptide Institute, and ﬂuorescent
(HiLyte Fluor 488)-labeled Aβ-42 (λex=503 nm, λem=528 nm)was
obtained from Anaspec.
2.2. Preparation of lipid vesicles
Cell-sized lipid vesicles (giant unilamellar vesicles (GUVs)) were pre-
pared from DOPC following the natural swelling method [24,26,32–34].
Phospholipids dissolved in chloroform/methanol (2:1, v/v) were poured
into a glass test tube. The organic solvent was then evaporated under a
nitrogen ﬂow and dried under vacuum to make a dry ﬁlm at the bottom
of the test tube. The tubewas placed in a desiccator for 3 h to remove the
organic solvent. The ﬁlmwas then swollen with Milli Q for 24 h at 37 °C.
The ﬁnal lipid concentration was 0.2 mM. Large unilamellar vesicles(LUVs) of DOPC and rho-PE were prepared by the extrusion method
[35] using membranes with 100-nm pores (Whatman, England).
2.3. Preparation of Aβ-peptides
Aβ-peptides were prepared in 0.02% ammonia solution at 0.2 mM
and stored at −80 °C. Just before analysis, and after equilibration at
room temperature (24±1 °C (RT)), the peptides (80 μM) were diluted
in 20 mM Tris/HCl buffer, pH 7.4 (TBS), and allowed to spontaneously
aggregate in TBS at 37±1 °C for a deﬁned period of time. Unless other-
wise stated, all analyses were carried out at RT.
Kinetics of Aβ ﬁbril formation was analyzed using Thioﬂavine T
(ThT) ﬂuorescence assay. Fluorescence intensity was monitored at
an excitation wavelength of 450 nm and an emission wavelength of
483 nm using a spectroﬂuorophotometer (Jasco FP-6500, Japan).
Aβ morphology was imaged using an AFM unit (SPA400-SPI3800,
Seiko Instruments Inc., Japan). Prior to analysis, the sample was prepared
by dilutionwithMilli Q to a ﬁnal concentration of 8 μM, and immobilized
on clean mica disk (Furuuchi Chemical, Japan). All AFM images were
obtained in air in a dynamic force mode (DFM mode) at optimal force.
All AFM operations were done in an automated moisture control box
with 30–40% humidity at RT. Direct Observation of Aβ assemblies was
conducted using a total internal reﬂection ﬂuorescence microscopy
(TIRFM) system used to observe individual Aβ (ﬁnal concentration of
2 μM) assemblies was developed based on an inverted microscopy
(Olympus IX-71, Japan). The ﬂuorescent image was ﬁltered with a
bandpass ﬁlter (DM505).
Zeta potential of each Aβ assemblies was detected at 25 °C with a
Zetasizer Nano ZS (Malvern Instruments, United Kingdom) at a protein
concentration of 40 μM in Tris–HCl buffer (pH 7.4). Each measurement
was performed on a freshly extracted aliquot of the protein sample kept
at 37 °C for aggregation.
2.4. Microscopic observation
Aβ-peptides were added to lipid vesicles to a ﬁnal concentration
of 2 μM, and visualized using a phase-contrast microscopy (Olympus
BX-51, Japan). Membrane vesicular responses were captured in
real-time at 30 frames/s [26].
Using an oil-in-water micro-droplet system [30], lipid organization
in the droplet section were observed using a laser confocal microscopy
(Olympus FV-1000, Japan) at RT. Diodelasers (473 nm) were used to
excite ﬂuorescence labeled Aβ, 488-Aβ, respectively.
For membrane fusion studies, LUVs and Aβ-peptides were pre-mixed
before introduction to GUVs. Examination was carried out using a laser
confocal microscopy (Olympus FV-1000, Japan). In GUV and GUV fusion
experiments, 10 μL sample of GUV solution (0.2 M sucrose solution;
internal solution) was diluted into 70 μL of 0.2 M glucose aqueous
solution (external solution). The resulting mixture was then transferred
into a handmade microchamber. The external solution containing 2 μM
of Aβ-42was added into a GUV through a 10-μm-diameter glassmicropi-
pet, the position of which was controlled by a micromanipulator (MN-4,
Narishige, Japan). we positioned the micropipet containing Aβ-42
solution in the chamber near a GUV, we added a small amount of
Aβ-42 solution, and observed shape changes in the two GUVs using
the phase-contrast microscopy (Olympus IX-71, Japan).
3. Results
3.1. Membrane dynamics induced by Aβ-peptides
We have investigated the effect of different Aβ-42 aggregation
species onmembrane instability, observed as ﬂuctuation and/or transfor-
mation. All Aβ species (from small oligomers to mature ﬁbrils) induced
membrane transformation, and four typical pathways were observed:
(1) membrane ﬂuctuation only, (2) exo-ﬁlament formation, (3) tubule
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spatio-temporal membrane transformation events can be seen in Movie
S1 in supporting information (SI). The sphero-stomatocyte pathway
resulted in increase in membrane surface area, and a decrease in inner
volume, which was not the case for the small sphero-stomatocyte. We
will discuss the signiﬁcance of the surface area later in this report. AFM
images showing the morphology of Aβ-42 species introduced to the ves-
icle can be seen in Fig. S1 in SI.
3.2. Association of Aβ-peptides with lipid membranes
In order to further elucidate the diverse membrane responses due
to differences in Aβ oligomeric species, we investigated the degree
of membrane association with each species. Because it was rather
problematic to clearly capture the localization of ﬁbrillar species with
respect to the vesicles under the objective lens, simultaneously, we
have used an oil-in-water micro-droplet system to allow a clear demon-
stration of ﬁbril localization [30]. Fig. 2 shows representative confocal
laser microscopic images of ﬂuorescent-labeled Aβ-42 aggregation spe-
cies associationwith vesicles. Oligomeric species of Aβ-42 localized close-
ly with the membrane surface (Fig. 2A and B) in agreement with our
previous report with the shorter Aβ isoform [29,30] and oil-in-water
micro-droplet experiments with Aβ-40 (Fig. S2 in SI). After 48 h
incubation, the images show oligomeric species to be associated the
membrane, and some ﬁbrillar species to be suspended within the
droplet membrane (Fig. 2C). Presence of a mixture of species within the
same period of incubation is expected to be the norm [36,37]. After
48 h of incubation, we could mainly observe ﬁbrillar species as indicated
in the AFM images (Fig. S1). Interestingly, some species from the same
incubation period were observed as shorter ﬁbrils and these localized
on the membrane (Fig. 2D). The change in morphology in the presence
of the membrane lipid could be ‘reverse’ or ‘backward’ oligomerization,
a phenomenon reported previously [18].
3.3. Physico-chemical characterization of membrane dynamics induced
by Aβ-peptides
We characterized the vesicular transformations of the sphero-
stomatocyte pathway, in terms of the reduced volume (v) is a dimension-
less parameter that describesmembranemorphology in terms ofHelfrich
bending energy, and is deﬁned by the ratio of themembrane surface area
and vesicular volume [38,39]. We calculated the surface area and volumeFig. 1. Spatial-temporal changes in membrane structures induced by Aβ-42. Shape transfor
main categories: exo-ﬁlament formation (2), tubular formation (3), and sphero-stomat
conducted in real-time using a phase contrast microscope and images were recorded usingchanges just after addition of the peptide and just after inner bud
formation. Fig. 3 shows the reduced volume v of the obtained sphero-
stomatocyte and the radius of the inner bud r divided by R0 (initial
vesicular radius) for the sphero-stomatocyte vesicles after addition of
Aβ-42. The black line shows the relationship between the two variables
under a constant surface area (A), and the gray line shows this relation-
ship under a constant vesicular volume (V). The reduced volume was
calculated from v=V/(4π/3)R03. The vesicle coordinates were normal-
ized to the area of the unit sphere; v=1. The presence of Aβ-42, at all
assembly states, shifted all vesicles away from both curves because of
increase in A (mean value was 24.1±14.5%), and a decrease in inner
volume. These observations are similar to our earlier study with
Aβ-40 except that mature ﬁbrils of the shorter isoform did not cause
any change in surface area [26]. We conclude that the biophysical char-
acteristics of the sphero-stomatocyte pathways induced by Aβ-42 and
Aβ-40 oligomeric species are similar. Further, we are tempted to con-
clude that the mechanisms driving (large) sphero-stomatocyte pathway
may be crucial in understanding the mechanisms behind neurotoxicity,
and warrants investigation.3.4. Membrane fusion of GUVs and LUVs actuated by Aβ-peptides
The biophysical characterization above showed increase in vesicular
surface area. Previously, we hypothesized that the increase in surface
area was caused either by incorporation of peptide molecules within
the bilayer, and/or recruitment of smaller micelles and lipid molecules
from the extracellular environment of the cell [26]. Dante and col-
leagues reported that the presence of Aβ-42 increased the radii of vesi-
cles and concluded that such an increase could only be caused by
membrane fusion [31]. We, therefore, investigated if membrane fusion
did occur, and to what extent it was related to the assembled species.
We approached this investigation in two ways. First, we prepared two
types of lipid vesicles: cell-sized or giant unilamellar vesicles (GUVs)
and ﬂuorescence-labeled large unilamellar vesicles (LUVs), as acceptor
and donor vesicles, respectively.
We imaged membrane fusion between GUVs and LUVs actuated
by Aβ-peptides. Fig. 4 shows typical confocal microcopy images of
the fusion events. The ﬂuorescent-labeled donor LUV could be ob-
served on the surface of the membrane in the presence of Aβ (bot-
tom), but not in the control sample where LUVs were randomly
scattered, and did not localize with the GUV (top). Fig. 4B clearly
shows a tubular vesicular structure in the presence of Aβ-peptides.mation of DOPC liposomes in the presence of various assemblies of Aβ-42 fell in three
ocyte formation (scale bars are 10 μm); (n>20). Membrane dynamic studies were
CCD camera at 30 frames/s.
Fig. 2. Laser confocal microscope images of DOPC micro-droplets encapsulating each incubation periods of HyliteFluor488-labeled Aβ 42. (A) 0 h, (B) 12 h, (C) and (D) 48 h.
(A)–(D) Differential interference images (Left) ﬂuorescence images (Center) and schematic illustrations (right) of each Aβ-42 assemblies. Respective relative ﬂuorescence intensity
proﬁles at a white dotted lines in the ﬂuorescence images (center), which shows the localization of Aβ-42 in a micro-droplets (scale bar=20 μm). The green colors in the micro-
scopic images are pseudo colors representing relative ﬂuorescence intensities of the peptide at the x-section indicated (broken line).
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stomatocyte formation (Fig. 1). The results strongly suggest that mem-
brane fusion may at least be one of the causes of surface area increase.
We then counted the number of ﬂuorescent GUVs showing fusion with
LUVs and no-ﬂuorescent GUVs. In total, we considered 30 individual lipo-
somes and calculated the frequency of fusion events as a percentage of
the number of fused vesicles over the total number of vesicles. TheFig. 3. Physico-chemical characterization of Aβ-42. Volume fraction (v) of transformed
liposomes plotted against the radius of the inner bud r for the sphero-stomatocyte.
Surface area constant (black line) and inner volume constant (gray line) are shown.
(Aβ-42_12h: white circle, Aβ-42_48h: white square).frequency of fusion events induced by different species of the peptide is
presented in Fig. 4C. Oligomeric species induced the highest occurrence
of fusion.
3.5. Membrane fusion of GUVs and GUVs actuated by Aβ-peptides
Next, we studied the fusion process using GUVs, in real-time.
In order to achieve this in a reasonable period of time, that is less
than 1 h so that there is virtually no evaporation of the reactants,
we micro-localized GUV to contact another GUV using a micropipet.
Then, we injected 2 μM Aβ solution through close to the two GUVs.
During the addition of peptide, the two GUVs were immediately ob-
served to associate with each other, and membrane ﬂuctuation en-
sued (Fig. 5A and Movie S2). We then observed a gradual increase
in the contact area between two GUVs. Further addition of Aβ in-
duced membrane fusion between these GUVs to produce a larger
spherical GUV. At times, membrane fusion did not occur. Instead,
we observed a semi-fused state (Fig. 5B). The frequency of fusion
events (including semi-fusion) was 40% of the total.
4. Discussion
4.1. Aβ mediates membrane fusion
Structural organizations such as lipid packing are intrinsic proper-
ties of cell membranes and contribute to biophysical processes such
as endo-, exo-cytosis, and membrane fusion. Membrane fusion events
play a role in fertilization, transmission of neurotransmitters across
Fig. 4. Aβ-peptides induce GUVs and LUVs membrane fusion. Typical confocal images of DOPC GUVs after 10 min of incubation at room temperature with DOPC/Rhodamine-DHPE
LUVs in the absence (A) and the presence (B) of 2 μM Aβ-42 imaged using a confocal microscope. Frequency of membrane fusion events driven by the presence of various Aβ-42
species were imaged using a confocal microscope. We counted the ﬂuorescent and transformed GUVs which show fusion of GUVs with labeled LUVs. These periods correspond to
small oligomeric, oligomeric and ﬁbrillar species of the peptides, in this increasing order (n=30) (C). Scale Bar=10 μm.
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nents such as signaling molecules [1–3]. Dante and colleagues
reported that Aβ-42 increased membrane radii of large unilamellar
vesicles (LUVs), using small-angle neutron scattering technique
[31]. They proposed that the increase in the surface area of the vesi-
cles (doubling) was due to Aβ inducing membrane fusion because
such an increase could not be explained by an increase in area per
molecule of lipid or by the areas occupied by an inserted peptide. Pre-
viously, our group had observed surface area increase of about 25%, in
the presence of Aβ-40 and proposed that either peptide insertion, or
more likely, recruitment of free lipids and small vesicles to the moth-
er vesicles was responsible for the increase [26]. In this current study,
using bothﬂuorescent-labeled donor LUVs and real-time observation of
fusion between GUVs we have clearly demonstrated that Aβ-peptides
mediate membrane fusion. Dante and colleagues further reported that
the presence of Aβ-42 and subsequent mediation of membrane fusion
did not cause any membrane shape changes, but suggested that the fu-
sion process may contribute to cytotoxicity by destabilizing the cell
membrane. Our work has clearly visualized membrane perturbation
of GUVs just before fusion (Fig. 5 A&C and Movie S2 in SI). We have
also observed membrane transformation in the presence of Aβ. Mem-
brane dynamics such as ﬂuctuations and transformations are caused
by (i) a decrease of the bending modulus and/or (ii) a decrease in
volume (V) to area (A) ratio such as the one we have reported. The
role of Aβ as a fusogenic peptide is not yet clear at this juncture. For
now, we simply note that the membrane fusion obeys the stalk model[40–42]. In stalkmodel, following the formation of a stalk between asso-
ciated vesicles, a semi-fusionoccurs followedby formationof a bilayer be-
tween the associated vesicles. In our work, Aβ binds to the membrane,
initiating membrane ﬂuctuation. During the next stage, a stalk is formed
at the fusion site, followed by formation of a semi-fusion intermediate.
The ﬁnal stage of the stalk model, a so-called fusion pore is formed and
its size increases with time. The interaction between Aβ and the mem-
brane surface causes general indirect disruption to the membrane's
roles such as possible disruption of signal transduction through inﬂuenc-
ing function and sensitivity of membrane-bound receptors. Aβ directly
changes membrane biophysical properties such as ﬂuidity [43] which in
turn (i) leads to changes in membrane dynamics such as ﬂuctuation,
fusion and transformation as reported above and previous work [26],
(ii) affects how the peptide translocate (membrane penetration and
vesicular transportation) to inner organelle such including mitochondria
and endoplasmic reticulum. Once inside the cell, Aβ has been reported to
disrupt vital organelle activities such as mitochondria by changing the
balance between ﬁssion and fusion events [7–9]. Wang and colleagues
recently showed that Aβ induced mitochondrial fragmentation in a
concentration-dependent manner [44].
We are conducting further studies to elucidate what the physio-
logical role of Aβ as a fusogenic peptide is likely to be. Aβ induced
membrane dynamics by changing membrane ﬂuidity and curvature.
This change in the membrane physical property causes membrane
dynamics, and could eventually lead to endocytosis, and transporta-
tion Aβ-peptides encapsulated within the endocytic vesicles. We
Fig. 5. Aβ-peptides induce GUVs and GUVs membrane fusion. Phase contrast images of membrane fusion (the white crosses show liposomes involved in the fusion process) (A), and
semi-fusion (B) of DOPC GUVs induced by addition of 2 μM Aβ-42. (C) Scheme of the proposed mechanism of Aβ-42-induced membrane fusion of DOPC-GUVs. Scale Bar=10 μm.
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tion [29] and vesicular transportation within the endocytic vesicles, in
particular, formation of sphero-stomatocytes. We propose that this
transformation route following fusion may not be coincidental. We vi-
sually demonstrate formation of a sphero-stomatocyte. The contents
of the endo-sphere contain amyloid beta peptides.
4.2. Effect of Aβ isoforms on membrane dynamics and fusogenic potential
Themembrane was perturbed in the presence of Aβ-peptides. Fig. 6A
shows the frequency of membrane dynamics (ﬂuctuation and morpho-
logical changes) in the presence of Aβ-42 at each assembly states. And
also, comparing Aβ-40 and Aβ-42 (at equivalent assembly states) shows
that the longer isoform induced a higher frequency ofmembrane dynam-
ics (Fig. S5). In addition, the bar graph details the types and breakdown of
membrane transformations that occur depending on the aggregation
species of Aβ-42 (Fig. 6B). The presence Aβ-40 perturbed the membrane
in an aggregation-dependent manner. The large oligomeric species had
the most impact at ~75% compared to the small oligomers (~43%). The
ﬁbrillar species had the least effect, but still noteworthy at ~38%
(Fig. S5). The difference in aggregation species on the frequency of
membrane dynamicswas not signiﬁcant for Aβ-42. This is indeed intrigu-
ing because amyloid ﬁbrils are increasingly being accepted as inert
species. We shall discuss this point in the next sub-section.
Aβ-40 has a slightlymore negative zeta potential thanAβ-42 (Fig. S3
in SI). This suggests that Aβ-42 may associate more closely with the
DOPC lipid vesicle (which is, although zwitterionic, partially negatively
charged). It has been reported that the afﬁnity of Aβ-42 for cells and
model membranes was slightly higher (~20%) than Aβ-40 [28]. In addi-
tion, through hydrophobic interactions, the extra two hydrophophic
amino acid residues may render the interaction between Aβ-42 and
the lipid vesicle stronger compared to Aβ-40. They also reported the
amyloidogenic activity (based aggregation rate) was 10 fold higher forAβ-42 than Aβ-40 [28]. We propose that a number of factors may play
a role in the high ‘amyloidogenicity’ Aβ-42. These include the higher as-
sembly rate, the higher afﬁnity for lipidmembranes due to the presence
of extra hydrophobic amino acid residues, the contribution by the
not-so-inert ﬁbrillar species, and the possible reverse oligomerization
of the ﬁbrillar species by the lipid membrane [18].
We then compared the fusogenic potential of the two isoforms. Fig. S4
in SI has shown that Aβ-42 has a greater membrane fusogenic potential
than Aβ-40. In addition, we wanted to elucidate why the two isoforms,
had different fusogenic potentials, given the fact that they both caused a
similar increase in membrane surface area. We calculated the rate at
which surface area increase was attained (Fig. S6 in SI). Analysis of the
manner in which surface area increased shows that surface area increase
was induced by Aβ-42 that was greater than Aβ-40. This ﬁnding is im-
portant and open up an understanding of how efﬁcient physiological
membrane fusion reactions, mediated by fusogenic peptides, may be
achieved. We therefore propose that rapid attainment of equilibrium
by the membrane is physiologically preferred following fusion.
4.3. The potential role of membrane dynamics as an early sensor of Aβ-
induced toxicity
In agreement with many recent reports, the frequency of mem-
brane destabilization, was higher in the presence of Aβ-42 than
with Aβ-40 [28,36,45]. Perhaps most importantly, our results demon-
strate that real-time membrane responses could be used as a sensor
for onset of neurotoxicity. It is uncanny how they correlate very high-
ly. A potential area of contention is that our studies (Fig. 6A) clearly
show that Aβ-42 ﬁbrillar species had a comparable inﬂuence on
membrane instability as the oligomeric species. These species are
reported as largely inert. We hypothesize that these species may re-
verse oligomerize in the presence of lipids. Martins and colleagues
reported the effect of lipid compositions on reverting amyloid ﬁbril
Fig. 6. Effect of peptide aggregation species onmembrane transformations. (A) Frequency
of membrane dynamics upon induction by Aβ-42 at indicated aggregation species.
(n>20). (B) Transformation diversity of liposome by Aβ-42 at indicated aggregation
species.
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stretching the role of using membrane responses as early sensors of
toxicity, without further studies that are currently in progress and
outside the main focus of this paper.
5. Conclusion
In this work, we have systematically investigated the interaction be-
tween Aβ-42 and lipid membranes and the resulting morphological
transformation of the lipid vesicles. We have shown that Aβ oligomeric
species localized closer to the membrane surface. Localization of the ﬁ-
brillar species of Aβ-42 (more amorphous and ﬁlamental compared to
those of Aβ-40)was varied. Someof the shorter species localized closely
with the membrane surface while the longer ones did not. We demon-
strated that the presence of Aβ-42 lead to an increase inmembrane sur-
face area, inducing lipid vesicular transformation. Butmost importantly,
we have revealed that Aβ-peptides mediate membrane fusion, and that
this fusion may be one of the mechanisms behind the membrane
increas is surface area and the resulting vesicular transformation.
Through two types of experiments: (i) we observed incorporation of
labeled LUVs within mother GUVs, and (ii) real-time fusion of GUVs.
This fusion is clearly one of the main mechanisms behind the increase
in membrane surface area that causes membrane transformation. In
addition, we have shown that the longer more ‘amyloidogenic’ isoform
(i) causes vesicular transformation more readily, and (ii) has a higher
membrane fusogenic potential than Aβ-40. We have shown that the
Aβ-42 ﬁbrillar species are shorter than Aβ-40 ﬁbrils, and perhaps
explaining why these ‘inert’ species induced membrane dynamics at a
higher frequency than expected. Last, the membrane dynamics and
their high agreement to reported amyloidogenicity of the peptides
and aggregation species open-up the potential role of vesicular dynam-
ics for proﬁling and bio-sensing of Aβ-induced neuro-toxicity.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.bbamem.2013.01.015.
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